Privacy Policy

Login

Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

Intresserad av platformen MFN för nyhetsdistribution?

Tisdag 22 September | 19:03:38 Europe / Stockholm

Svenska | English

Impala Nordic

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

OncoZenge - Interview with Torben Mogensen: One of the BupiZenge™ co-inventors

2024-09-10 13:30:00

Impala Nordic has interviewed Torben Mogensen, one of the co-inventors behind OncoZenge AB (publ)'s drug candidate, BupiZenge™.

In the interview, Torben Mogensen shares insights into his background in anesthesiology and explains how the idea for BupiZenge™ was conceived. Additionally, Mogensen discusses the medical need for patients suffering from oral mucositis and shares his hopes for the future of BupiZenge™.

Click here to read the full interview